5. Understanding the Risks of Healthcare Investing
Biotech investing is hard and risky. Most biotech companies fail. Biotech stocks are notoriously volatile. They are not for the risk averse and certainly not a place to invest money you need in the near future.1 It is hard to predict which biotech companies will succeed. Within this tough investing environment, investors benefit from understanding the drug development and approval process and other factors that affect the value of the stocks of publicly traded biotech companies and their chances of success. To access this market and minimize the great risks, investors need to invest in baskets of biotech stocks—and ETFs make it easy to do. (The various ETFs are covered in Chapter 6, “Investing ...
Get Three Paths to Profitable Investing: Using ETFs in Healthcare, Infrastructure, and the Environment to Grow Your Assets now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
